Partner Therapeutics, Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Partner Therapeutics, Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Partner Therapeutics, Inc.

Partner Therapeutics, Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by ZENOCUTUZUMAB. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: advanced unresectable, harboring neuregulin, nrg gene, disease progression, prior systemic, treatment adults, non-small cell, lung cancer. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
ZENOCUTUZUMAB 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAVENOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Partner Therapeutics, Inc.

Brand nameGenericTypeRoute
BIZENGRI ZENOCUTUZUMAB HUMAN PRESCRIPTION DRUG INTRAVENOUS

Frequently asked questions

How many FDA drug products does Partner Therapeutics, Inc. make?
1 FDA drug label records name Partner Therapeutics, Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Partner Therapeutics, Inc. produce?
The most frequent active ingredients in this portfolio are ZENOCUTUZUMAB.

Are Partner Therapeutics, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.